✦ LIBER ✦

In vivo dynamics and pathogenicity of wild-type and resistant Hepatitis B virus during long-term lamivudine monotherapy — a clinical note

✍ Scribed by Bernhard Zöllner; Albrecht Stoehr; Andreas Plettenberg; Heinz-Hubert Feucht; Matthias Schröter; Peter Schäfer; Rainer Laufs

Book ID: 117769320
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 96 KB
Volume: 17
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(00)00092-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro activity of cepharanthine hydro

In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates

✍ Yu-Bing Zhou; Ya-Feng Wang; Yan Zhang; Li-Yun Zheng; Xiao-Ang Yang; Ning Wang; J 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 558 KB

Lamivudine monotherapy in HBeAg-negative

Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcome

✍ S. MANOLAKOPOULOS; S. BETHANIS; J. ELEFSINIOTIS; S. KARATAPANIS; C. TRIANTOS; G. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Virus and transaminase levels determine

Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B

✍ Ming-Ling Chang; Rong-Nan Chien; Chau-Ting Yeh; Yun-Fan Liaw 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Emergence and takeover of YMDD motif mut

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

✍ Kazuaki Chayama; Yoshiyuki Suzuki; Masahiro Kobayashi; Mizuho Kobayashi; Akihito 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

Treatment of hepatitis B virus (HBV) with lamivudine is effective in suppressing virus replication and results in reduced inflammatory activity. However, the emergence of lamivudine-resistant mutant virus, with amino acid substitution in the YMDD motif of DNA polymerase, has been reported. We report

A randomized study comparing lamivudine

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation

✍ Marı́a Buti; Antoni Mas; Martı́n Prieto; Fernando Casafont; Antonio González; Ma 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 115 KB